Industry

The Funding Will Support New Research Initiatives Around Brain Health and Increasing Accessibility to The Company’s EEG Technology Platform TORONTO–(BUSINESS WIRE)–Interaxon Inc. ( Muse®), the leading consumer neurotechnology company, announced that it has closed an oversubscribed $9.5M USD Series C funding round through a non-brokered private placement. The round was led by BDC Capital, Alabaster … [Read more…]

Surest™, formerly Bind, offers a new approach to health benefits that eliminates deductibles and offers access to clear, upfront pricing information before people access care Surest members show improved satisfaction; plans offer up to 15% lower health care costs for employers and reduced member out-of-pocket expenses by up to 44%1 MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare’s Surest offers … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Celiac Disease Drugs Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The celiac disease drugs market is poised to grow by $601.57 mn during 2022-2026, accelerating at a CAGR of 16.95% This study identifies the inorganic growth strategies as one of the prime reasons driving the celiac diseases drugs market growth … [Read more…]

–9,200 dermatology prescribers now use the tech platform to improve affordability and accessibility for skincare prescriptions– NEW YORK–(BUSINESS WIRE)–Skin Medicinals today announced that over 9,200 dermatology prescribers have joined its platform, saving millions of dollars for over 450,000 patients. Combatting years of escalating drug prices, dermatologists have started fighting back by using technology to greatly … [Read more…]

Following Successful Pilots with Leading Healthcare Organizations, Abridge’s Ambient AI Technology is Positioned to Transform Medical Documentation Workflows and Revolutionize the Care Delivery Experience for Providers and Patients PITTSBURGH–(BUSINESS WIRE)–Abridge, the leader in medical conversation AI, today announced an oversubscribed $12.5M Series A-1. Led by Wittington Ventures, the round also had participation from all existing … [Read more…]

Donations Made to St. Baldricks and One Mission at Recent Ceremony BOSTON, Mass.–(BUSINESS WIRE)–#AI–Hack/Reduce, a non-profit focused on creating talent and technologies for Boston’s big data-driven economy, today announced that more than $320,000 has been raised to fight pediatric cancer-related causes from its sixth annual Tech Tackles Cancer (TTC) event. “The event was a tremendous … [Read more…]

Investment in Response to Increased Demand for North American-Based Chemistry Services OAKVILLE, Ontario–(BUSINESS WIRE)–GL CHEMTEC (“GLC”), a specialist in advanced chemistry R&D and scale-up services to support Active Pharmaceutical Ingredient (“API”) development, and the development of advanced materials for drug delivery, medical devices, and other life science applications, today announced it is partnering with Edgewater … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Viscoelastic Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. Ophthalmic Viscoelastic Devices Market Report is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area. The model discusses in detail the … [Read more…]

Series C financing to support regulatory process and initial market entry of the Levita® MARS™ platform designed to make robotic surgery accessible for all MENLO PARK, Calif.–(BUSINESS WIRE)–Levita Magnetics, on a mission to provide patients with more access to better surgery, today announced the closing of its $26 million Series C financing, which will be … [Read more…]

MORRISTOWN, N.J.–(BUSINESS WIRE)–Alvogen, a privately held pharmaceutical company focused on developing, manufacturing and selling generic and branded products, announced today a favorable district court ruling on multiple patents related to the company’s proposed generic to Xifaxan®, a treatment for irritable bowel syndrome with diarrhea (IBS-D) in adults. “We are extremely pleased with the district court’s … [Read more…]